FindMyKOL
Clinical trialNCT00000867CompletedPhase 2Interventional

A Study to Evaluate the Use of Memantine In Combination With Anti-HIV Drugs to Treat AIDS Dementia Complex (ADC)

SponsorNational Institute of Allergy and Infectious Diseases (NIAID)Enrollment120AIDS Dementia ComplexHIV Infections
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to determine the safety and effectiveness of memantine, an experimental drug, in improving AIDS dementia complex (ADC). The symptoms of ADC can be improved with zidovudine (ZDV). However, ZDV therapy has been associated with significant toxicities, and the effectiveness of ZDV seems to decrease during the second and third years of therapy. The effectiveness of other antiretroviral drugs as treatment for ADC is not known, so it is important to explore alternative therapies.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

19 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Ucla Care Center Crs

    Los Angeles, California, United States

  • Ucsf Aids Crs

    San Francisco, California, United States

  • Univ. of Miami Aids Crs

    Miami, Florida, United States

  • Queens Med. Ctr.

    Honolulu, Hawaii, United States

  • Univ. of Hawaii at Manoa, Leahi Hosp.

    Honolulu, Hawaii, United States

  • Cook County Hosp. Core Ctr.

    Chicago, Illinois, United States

  • Northwestern University Crs

    Chicago, Illinois, United States

  • the Univ. of Kentucky, Lexington A2405 Crs

    Lexington, Kentucky, United States

  • Beth Israel Deaconess - East Campus A0102 Crs

    Boston, Massachusetts, United States

  • Bmc Actg Crs

    Boston, Massachusetts, United States

  • Washington U Crs

    St Louis, Missouri, United States

  • Univ. of Nebraska Med. Ctr., Durham Outpatient Ctr.

    Omaha, Nebraska, United States

  • Suny - Buffalo, Erie County Medical Ctr.

    Buffalo, New York, United States

  • Beth Israel Med. Ctr. (mt. Sinai)

    New York, New York, United States

  • Mt. Sinai Med. Ctr. (n.Y.) A1801 Crs

    New York, New York, United States

  • Mt. Sinai Med. Ctr. A0404 Crs

    New York, New York, United States

  • Univ. of Rochester Actg Crs

    Rochester, New York, United States

  • Hosp. of the Univ. of Pennsylvania Crs

    Philadelphia, Pennsylvania, United States

  • University of Washington Aids Crs

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Dec 1996
Primary completion
—
Completion
31 Jul 2001
Last update posted
10 Jun 2013
Registered enrollment
120
Registry id
NCT00000867

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.